Organon, Others Want $421M Medicaid FCA Suit Tossed

Law360, New York (July 8, 2011, 5:05 PM EDT) -- Organon USA Inc., Merck & Co. Inc. and Schering Plough Corp. asked a Massachusetts federal court Thursday to dismiss a False Claims Act suit by ex-Organon employees accusing them of concocting a kickback scheme that helped overcharge the government by $421 million.

The relators claim the drug companies engaged in a variety of illegal kickbacks to long-term care pharmacies that sold the antidepressant Remeron, and defrauded the government by violating the Anti-Kickback Statute, the FCA and Medicaid “best price” laws.

The drug companies said that any...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.